Advanced Biomed Net Income From Continuing Ops Over Time
| ADVB Stock | 0.30 0.01 2.24% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Advanced Biomed Performance and Advanced Biomed Correlation. Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Advanced Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Advanced Biomed Common is measured differently than its book value, which is the value of Advanced that is recorded on the company's balance sheet. Investors also form their own opinion of Advanced Biomed's value that differs from its market value or its book value, called intrinsic value, which is Advanced Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Advanced Biomed's market value can be influenced by many factors that don't directly affect Advanced Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Advanced Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Advanced Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Advanced Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income From Continuing Ops Analysis
Compare Advanced Biomed Common and related stocks such as BioNexus Gene Lab, Trinity Biotech plc, and Ridgetech Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BGLC | 26.5 K | 26.5 K | 26.5 K | 26.5 K | 26.5 K | 26.5 K | 26.5 K | 26.5 K | 26.5 K | (246.5 K) | 1.4 M | 795.1 K | (356 K) | (3.1 M) | (1.6 M) | (1.4 M) | (1.4 M) |
| TRIB | 9.6 M | 9.6 M | 9.6 M | 9.6 M | 14.9 M | 22.2 M | (38.6 M) | (38.7 M) | (22.7 M) | (29 M) | 15.7 M | 9.2 M | (41 M) | (36.9 M) | (31.2 M) | (28.1 M) | (26.7 M) |
| RDGT | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (8.4 M) | (3.2 M) | (21.1 M) | (4.2 M) | (1.5 M) | (1.7 M) | (1.8 M) |
| APM | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (3.2 M) | (15.1 M) | (20.1 M) | 4.9 M | (27.1 M) | (11.5 M) | (4.3 M) | (4.2 M) | (3.7 M) | (3.9 M) |
| XAIR | (29.7 K) | (29.7 K) | (29.7 K) | (29.7 K) | (29.7 K) | (29.7 K) | (68.2 K) | (18 M) | (6.6 M) | (19.9 M) | (22.9 M) | (44.1 M) | (59.4 M) | (64.3 M) | (48.5 M) | (43.6 M) | (45.8 M) |
| MRKR | 1.5 M | 1.5 M | 1.5 M | 1.5 M | (30.3 M) | (6.1 M) | (2.5 M) | (11 M) | (148 M) | (21.4 M) | (28.7 M) | (41.9 M) | (29.9 M) | (24.5 M) | (10.7 M) | (9.7 M) | (10.1 M) |
| MBIO | (5.4 M) | (5.4 M) | (5.4 M) | (5.4 M) | (5.4 M) | (5.4 M) | (12.7 M) | (31.3 M) | (30.7 M) | (46.4 M) | (60 M) | (66.4 M) | (77.5 M) | (62.6 M) | (15.8 M) | (14.2 M) | (14.9 M) |
| TNON | (705.4 K) | (705.4 K) | (705.4 K) | (705.4 K) | (705.4 K) | (705.4 K) | (705.4 K) | (705.4 K) | (705.4 K) | (705.4 K) | (705.4 K) | (7.1 M) | (18.9 M) | (20.4 M) | (13.7 M) | (12.3 M) | (12.9 M) |
| GELS | (648.9 K) | (648.9 K) | (648.9 K) | (648.9 K) | (648.9 K) | (648.9 K) | (648.9 K) | (648.9 K) | (648.9 K) | (648.9 K) | (648.9 K) | (3.4 M) | (3.5 M) | (3.5 M) | (6.6 M) | (6 M) | (5.7 M) |
Advanced Biomed Common and related stocks such as BioNexus Gene Lab, Trinity Biotech plc, and Ridgetech Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| Advanced Biomed Common | ADVB |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 122 East 42nd |
| Exchange | NASDAQ Exchange |
null 0.2965
Check out Advanced Biomed Performance and Advanced Biomed Correlation. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Advanced Biomed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.